Effect of Countermeasures on Nocturnal Driving Performance
KILLSLEEP
Countermeasures for Sleepiness at the Wheel and Prediction of Inter- Individual Differences to Their Responses (KillSleep)
1 other identifier
interventional
72
1 country
2
Brief Summary
Sleep deprivation induces degradation of night-time driving ability via sleepiness. Because of conflicts between physiological needs and social or professional activities, it is necessary to develop affordable countermeasure to sleepiness. In real-life driving studies, nap and coffee are efficient countermeasures of sleepiness at the wheel. However the effect of caffeine is quick but brief and varies between individuals. There is a need for more knowledge in order to know what to recommend to drivers. Exposure to 460-nm monochromatic light (blue light) decreases subjective sleepiness and improves performances. One objective of this project is to investigate whether blue light exposure during driving would be useful in a real driving situation when sleepiness becomes acute. Owing to the fact that our knowledge of the effects of exercise on driving is very sparse and to the absolutely need to standardize the bouts of exercise that will be applied to the subjects. One objective of the present study will be to investigate in a simulator study the effects of a bout of moderate exercise on participants driving ability when sleepiness becomes acute. Nocturnal neurobehavioral performance varies widely between individuals and only certain subjects seem significantly affected by sleep loss. It is of interest to find biological markers for sleep drive to identify vulnerable drivers to sleep deprivation or to identify responders to sleepiness countermeasures (i.e., coffee and blue light). One objective of this study is to determine individual differences (genetic, hormonal and cognitive) in the impairment of driving skills induced by sleep loss and in the efficiency of countermeasures (blue light and coffee).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2010
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 15, 2010
CompletedFirst Posted
Study publicly available on registry
February 17, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2011
CompletedJune 14, 2012
June 1, 2012
1.6 years
February 15, 2010
June 13, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of inappropriate line crossings identified from video recordings
First, second and third visit
Secondary Outcomes (12)
Standard deviation of the position of the car identified from the video recordings
First, second and third visit
Self-rated sleepiness during driving
First, second and third visit
Self-rated fatigue during driving
First, second and third visit
Sleep latency during subsequent sleep
after each driving session
sleep efficiency during the subsequent sleep
after each driving session
- +7 more secondary outcomes
Study Arms (2)
Blue light
EXPERIMENTALExposure to 460-nm monochromatic light (blue light)
Physical activity
EXPERIMENTAL15 minutes of physical activity at a low intensity
Interventions
Continuous blue light exposure during driving compared to effects of coffee (2\*200 mg of caffeine) and coffee placebo on 4h night-time real driving situation. Inside this arm, each volunteer will be randomly allocated and will all receive : continuous blue light exposure, coffee and coffee placebo at each driving session with at least 1 week between each condition.
15 minutes of physical activity at a low intensity before driving compared to effects of coffee (2\*200 mg of caffeine) and coffee placebo on 4h night-time driving simulator. Inside this arm, each volunteer will be randomly allocated and will all receive : 15 minutes of physical activity, coffee and coffee placebo at each driving session with at least 1 week between each condition.
Eligibility Criteria
You may qualify if:
- year-old healthy Volunteers or of 40-50 years, male, Caucasian,
- Presenting no disorder of the perception,
- Taking no treatment interfering with the sleep, the attentiveness and the circadian system,
- BMI ≥18 et ≤ 27
- Moderate Drinker of coffee(café) (2-3 cups a day) •
- Presenting no medical history or evolutionary pathology,
- Not presenting syndrome of apneas / hypopnea during the sleep (IAH \< 5 for 20-25 years and 10 for 40-50 years),
- Not presenting syndrome of periodic movements during the sleep (Index of MPS \< 15),
- Not professional Driver, having their driving license for at least 3 years or 2 years for the drivers who followed the learning anticipated and driving between 10000 and 20000 km a year,
- Having looked in writing their consent to participate in the study,
- Having regular schedules of life 3 days before going into the study,
- Registers on the Social Security and on the register of the healthy volunteers.
You may not qualify if:
- Night workers,
- Any evolutionary psychiatric affections (psychosis, disorder(confusion) of the mood or the anxiety),
- All the sleeping disorders (sleep apneas, periodic leg movements, narcolepsy, phase delay, advance of phase),
- Any evolutionary neurological affections (brain tumour, epilepsy, Headache, brain vascular accident, calcifies, myoclonia , chorea, neuropathy, muscular dystrophies, myotonic dystrophy),
- Cardiovascular Pathologies (arterial high blood pressure, cardiac insufficiency, coronary disease, vascular disorders(confusions)),
- Lung Pathologies (BPCO, BPR),
- Renal Disorders(Confusions) (renal insufficiency, nephrolithiases),
- Endocrine Pathologies (dysthyroid, diabetes),
- Drug addiction, alcoholic dependence during the last 6 months,
- Having made a trans-meridian journey (± 3 hours) in last 3 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Bordeauxlead
- ERANETcollaborator
- INSERM ERI27 Mobilités Cognition et Temporalitécollaborator
- Hotel Dieu Hospitalcollaborator
- IMF, CNRS UMR-5231collaborator
Study Sites (2)
CHU de Bordeaux Groupe Hospitalier Pellegrin
Bordeaux, 33076, France
Université de Caen Basse Normandie
Caen, 14032, France
Related Publications (1)
Taillard J, Capelli A, Sagaspe P, Anund A, Akerstedt T, Philip P. In-car nocturnal blue light exposure improves motorway driving: a randomized controlled trial. PLoS One. 2012;7(10):e46750. doi: 10.1371/journal.pone.0046750. Epub 2012 Oct 19.
PMID: 23094031DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Pierre Philip, Pr
University Hospital, Bordeaux
- PRINCIPAL INVESTIGATOR
Pierre Denise, Pr
INSERM ERI27
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 15, 2010
First Posted
February 17, 2010
Study Start
January 1, 2010
Primary Completion
August 1, 2011
Study Completion
August 1, 2011
Last Updated
June 14, 2012
Record last verified: 2012-06